These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 11464860

  • 1. Expression of Fas (APO-1/CD95) and Fas ligand (FasL) in human neuroblastoma.
    Gross N, Balmas K, Beretta Brognara C, Tschopp J.
    Med Pediatr Oncol; 2001 Jan; 36(1):111-4. PubMed ID: 11464860
    [Abstract] [Full Text] [Related]

  • 2. Induction of antitumor immunity with Fas/APO-1 ligand (CD95L)-transfected neuroblastoma neuro-2a cells.
    Shimizu M, Fontana A, Takeda Y, Yagita H, Yoshimoto T, Matsuzawa A.
    J Immunol; 1999 Jun 15; 162(12):7350-7. PubMed ID: 10358186
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H, Voss M, Jansen M, Roeder C, Henne-Bruns D, Kremer B, Kalthoff H.
    Cancer Res; 1998 Apr 15; 58(8):1741-9. PubMed ID: 9563493
    [Abstract] [Full Text] [Related]

  • 7. FK506 restores sensitivity of thymic lymphomas to calcium-mediated apoptosis and the inducible expression of Fas ligand.
    Kalas W, Matuszyk J, Ziolo E, Strzadala L.
    Anticancer Res; 2003 Apr 15; 23(2B):1613-7. PubMed ID: 12820430
    [Abstract] [Full Text] [Related]

  • 8. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C, Tohma Y, Barnas C, Taniere P, Hainaut P, Ohgaki H.
    Cancer Res; 1998 May 15; 58(10):2057-62. PubMed ID: 9605741
    [Abstract] [Full Text] [Related]

  • 9. Induction of Fas ligand (CD95L) by the toxic mistletoe lectins in human lymphocytes.
    Büssing A, Stein GM, Pfüller U, Schietzel M.
    Anticancer Res; 1999 May 15; 19(3A):1785-90. PubMed ID: 10470116
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Human lung carcinomas express Fas ligand.
    Niehans GA, Brunner T, Frizelle SP, Liston JC, Salerno CT, Knapp DJ, Green DR, Kratzke RA.
    Cancer Res; 1997 Mar 15; 57(6):1007-12. PubMed ID: 9067260
    [Abstract] [Full Text] [Related]

  • 12. The inhibitor of apoptosis protein survivin is associated with high-risk behavior of neuroblastoma.
    Azuhata T, Scott D, Takamizawa S, Wen J, Davidoff A, Fukuzawa M, Sandler A.
    J Pediatr Surg; 2001 Dec 15; 36(12):1785-91. PubMed ID: 11733907
    [Abstract] [Full Text] [Related]

  • 13. Human pancreatic cancer cells express non-functional Fas receptors and counterattack lymphocytes by expressing Fas ligand; a potential mechanism for immune escape.
    Elnemr A, Ohta T, Yachie A, Kayahara M, Kitagawa H, Ninomiya I, Fushida S, Fujimura T, Nishimura G, Shimizu K, Miwa K.
    Int J Oncol; 2001 Jan 15; 18(1):33-9. PubMed ID: 11115536
    [Abstract] [Full Text] [Related]

  • 14. Apoptosis in neuroblastomas induced by interferon-gamma involves the CD95/CD95L pathway.
    Annicchiarico-Petruzzelli M, Bernassola F, Lovat PE, Redfern CP, Pearson AD, Melino G.
    Med Pediatr Oncol; 2001 Jan 15; 36(1):115-7. PubMed ID: 11464861
    [Abstract] [Full Text] [Related]

  • 15. Hybrid polar histone deacetylase inhibitor induces apoptosis and CD95/CD95 ligand expression in human neuroblastoma.
    Glick RD, Swendeman SL, Coffey DC, Rifkind RA, Marks PA, Richon VM, La Quaglia MP.
    Cancer Res; 1999 Sep 01; 59(17):4392-9. PubMed ID: 10485488
    [Abstract] [Full Text] [Related]

  • 16. Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.
    Maas S, Warskulat U, Steinhoff C, Mueller W, Grimm MO, Schulz WA, Seifert HH.
    Urology; 2004 Feb 01; 63(2):392-7. PubMed ID: 14972509
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. c-FLIP expression in bladder urothelial carcinomas: its role in resistance to Fas-mediated apoptosis and clinicopathologic correlations.
    Korkolopoulou P, Goudopoulou A, Voutsinas G, Thomas-Tsagli E, Kapralos P, Patsouris E, Saetta AA.
    Urology; 2004 Jun 01; 63(6):1198-204. PubMed ID: 15183989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.